Chemical Structure 34.1
Ferrous sulfate
![A310120_1_En_34_Fig2_HTML.jpg](/wp-content/uploads/2016/09/A310120_1_En_34_Fig2_HTML.jpg)
Chemical Structure 34.2
Zinc sulfate
![A310120_1_En_34_Fig3_HTML.jpg](/wp-content/uploads/2016/09/A310120_1_En_34_Fig3_HTML.jpg)
Chemical Structure 34.3
Calcium carbonate
References
1.
Shils ME, Olson JA, Shike M. Modern nutrition in health and disease. 9th ed. Baltimore: Williams and Wilkins; 1999. p. 210–860, 1422, 1424, 1772.
2.
Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005;202:199–211.PubMed
6.
Davolos A, Castillo J, Marrugat J, et al. Body iron stores and early neurologic deterioration in acute cerebral infarction. Neurology. 2000;54:1568–74.
7.
Lao TT, Tam K, Chan LY. Third trimester iron status and pregnancy outcome in non-anemic women: pregnancy unfavorably affected by maternal iron excess. Hum Reprod. 2000;15:1843–8.PubMed
8.
Lehto P, Kivisto KT, Neuvonen PJ. The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin, and ofloxacin. Br J Clin Pharmacol. 1994;37:82–5.PubMedCentralPubMed
9.
Campbell NR, Hasinoff BB. Iron supplements: a common cause of drug interactions. Br J Clin Pharmacol. 1991;31:251–5.PubMedCentralPubMed
10.
Heinrich HC, Oppitz KH, Gabbe EE. Inhibition of iron absorption in man by tetracycline [German]. Klin Wochenschr. 1974;52:493–8.PubMed
11.
Osman MA, Patel RB, Schuna A, et al. Reduction in oral penicillamine absorption by food, antacid, and ferrous sulphate. Clin Pharmacol Ther. 1983;33:465–70.PubMed
12.
Campbell NR, Hasinoff BB, Stalts H, et al. Ferrous sulphate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med. 1992;117:1010–3.PubMed
13.
Hendler SS, Rorvik DR, editors. PDR for nutritional supplements. Montvale: Medical Exonomics, Inc; 2001.
14.
Minerals. Drug facts and comparisons. St. Louis: Facts and Comparisons. p. 27–30.
15.
Supplements and anesthesiology. In: Kelly Anne M, Kaye AD, Baluch A, Hoover J, editors. Nutrient-drug interactions. Chapter 7. CRC Press; 2006. p 209–36.
16.
AlZahrani A, Sinnert R, Gernsheimer J. Acute kidney injury, sodium disorders, and hypercalcemia in the aging kidney. Clin Geriatr Med. 2013;29:275–319.PubMed
17.
Bar-Or D, Gasiel Y. Calcium and calciferol antagonize effect of verapamil in atrial fibrillation. Br Med J (Clin Res Ed). 1981;282:1585–6.
18.
Durward A, Guerguerian AM, Lefebvre M, Shemie SD. Massive diltiazem overdose treated with extracorporeal membrane oxygenation. [Case Reports. Journal Article]. Pediatr Crit Care Med. 2003;4(3):372–6.PubMed
19.
Masharani U, Gjerde C, McCoy S, Maddux BA, Hessler D, Goldfine ID, Youngren JF. Chromium supplementation in non-obese non diabetic subjects is associated with a decline in insulin sensitivity. BMC Endocr Disord. 2012;12:31.PubMedCentralPubMed
20.
Broadhurst CL, Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus. Diabetes Technol Ther. 2006;8:677–87.PubMed
![](https://freepngimg.com/download/social_media/63059-media-icons-telegram-twitter-blog-computer-social.png)
Stay updated, free articles. Join our Telegram channel
![](https://clinicalpub.com/wp-content/uploads/2023/09/256.png)
Full access? Get Clinical Tree
![](https://videdental.com/wp-content/uploads/2023/09/appstore.png)
![](https://videdental.com/wp-content/uploads/2023/09/google-play.png)